Matt Pfeffer - Mbr of the Board - Acerus Pharma
Aug 9, 2017 15:00:58 GMT -5
sportsrancho, lakon, and 2 more like this
Post by otherottawaguy on Aug 9, 2017 15:00:58 GMT -5
I am putting this up as a place holder for further investigation.
I went to Linked in to see what Matt Pfeffer is currently up to and came across the little tidbit that he was on the Board of Directors:
Member Board of Directors
Company Name Acerus Pharmaceuticals Corporation
Dates Employed Nov 2013 – Jan 2016 Employment Duration2 yrs 3 mos
Location Toronto, Canada
Member of Audit and Compensation Committees (yes it was the audit committee)
Just seemed odd for a guy from Southern California to be associated with a Toronto Canada firm.
Took a look at ACERUS and came across their partnership statement (note that they are not in the diabetes space -see underlined) but the last paragraph still caught my eye.
----------------------
PARTNERSHIPS
Acerus is currently focusing its development efforts on creating new best-in-class versions of existing pharmaceutical compounds utilizing our novel nasal delivery platform.
In addition, we intend to pursue business development opportunities relating to on-market (or advanced-stage) commercial products through acquisition or in-licensing. We will prioritize acquisitions that align with our current focus in Men’s Health (Urology) and Women’s Health (Hormone Replacement Therapy, Female Sexual Dysfunction), or that provide cost or revenue synergies – especially for assets we are considering for our Canadian business. However, we are open to consideration of opportunities in other complimentary therapeutic areas.
We also have an interest in partnership with third parties in jurisdictions outside of Canada that have the requisite expertise in marketing pharmaceutical products, as well as sufficient resources to effectively commercialize our products at a favourable value inflection point for each of our pipeline programs.
Acerus offers in-house expertise at all stages of the pharmaceutical product lifecycle, from clinical and regulatory competency to full Canadian commercial sales and marketing capabilities.
------------------------------------
I have not seen anything on the Health Canada website directly referencing Afrezza but have only come across the following table entries:
Products for Human Use
Inhaled human insulin 2013-12-19
Products for Veterinary Use
Inhaled human insulin 2013-12-19
I went to Linked in to see what Matt Pfeffer is currently up to and came across the little tidbit that he was on the Board of Directors:
Member Board of Directors
Company Name Acerus Pharmaceuticals Corporation
Dates Employed Nov 2013 – Jan 2016 Employment Duration2 yrs 3 mos
Location Toronto, Canada
Member of Audit and Compensation Committees (yes it was the audit committee)
Just seemed odd for a guy from Southern California to be associated with a Toronto Canada firm.
Took a look at ACERUS and came across their partnership statement (note that they are not in the diabetes space -see underlined) but the last paragraph still caught my eye.
----------------------
PARTNERSHIPS
Acerus is currently focusing its development efforts on creating new best-in-class versions of existing pharmaceutical compounds utilizing our novel nasal delivery platform.
In addition, we intend to pursue business development opportunities relating to on-market (or advanced-stage) commercial products through acquisition or in-licensing. We will prioritize acquisitions that align with our current focus in Men’s Health (Urology) and Women’s Health (Hormone Replacement Therapy, Female Sexual Dysfunction), or that provide cost or revenue synergies – especially for assets we are considering for our Canadian business. However, we are open to consideration of opportunities in other complimentary therapeutic areas.
We also have an interest in partnership with third parties in jurisdictions outside of Canada that have the requisite expertise in marketing pharmaceutical products, as well as sufficient resources to effectively commercialize our products at a favourable value inflection point for each of our pipeline programs.
Acerus offers in-house expertise at all stages of the pharmaceutical product lifecycle, from clinical and regulatory competency to full Canadian commercial sales and marketing capabilities.
------------------------------------
I have not seen anything on the Health Canada website directly referencing Afrezza but have only come across the following table entries:
Products for Human Use
Inhaled human insulin 2013-12-19
Products for Veterinary Use
Inhaled human insulin 2013-12-19
